Washington Trust’s Quest Diagnostics DGX Stock Holding History

Washington Trust’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$224K	Buy	+960	New	+$222K	0.01%	274
2026 Q1	–	Sell	-1,300	Closed	-$226K	–	286
2025 Q4	$226K	Sell	1,300 -334	-20%	-$60.8K	0.01%	264
2025 Q3	$311K	Buy	+1,634	New	+$290K	0.01%	238
2025 Q2	–	Sell	-323	Closed	-$54.7K	–	370
2025 Q1	$54.7K	Buy	323 +23	+8%	+$3.78K	﹤0.01%	393
2024 Q4	$45.3K	Hold	300	–	–	﹤0.01%	454
2024 Q3	$46.6K	Hold	300	–	–	﹤0.01%	463
2024 Q2	$41.1K	Sell	300 -60	-17%	-$8.22K	﹤0.01%	470
2024 Q1	$47.9K	Hold	360	–	–	﹤0.01%	458
2023 Q4	$49.6K	Hold	360	–	–	﹤0.01%	429
2023 Q3	$43.9K	Hold	360	–	–	﹤0.01%	412
2023 Q2	$50.6K	Hold	360	–	–	﹤0.01%	419
2023 Q1	$50.9K	Hold	360	–	–	﹤0.01%	410
2022 Q4	$56.3K	Hold	360	–	–	﹤0.01%	382
2022 Q3	$44K	Hold	360	–	–	﹤0.01%	410
2022 Q2	$48K	Hold	360	–	–	﹤0.01%	411
2022 Q1	$49K	Hold	360	–	–	﹤0.01%	435
2021 Q4	$62K	Hold	360	–	–	﹤0.01%	407
2021 Q3	$53K	Hold	360	–	–	﹤0.01%	507
2021 Q2	$48K	Buy	360 +60	+20%	+$7.86K	﹤0.01%	528
2021 Q1	$39K	Hold	300	–	–	﹤0.01%	552
2020 Q4	$36K	Hold	300	–	–	﹤0.01%	553
2020 Q3	$34K	Hold	300	–	–	﹤0.01%	515
2020 Q2	$33K	Hold	300	–	–	﹤0.01%	462
2020 Q1	$24K	Buy	+300	New	+$31.1K	﹤0.01%	516
2018 Q3	–	Sell	-1,013	Closed	-$111K	–	377
2018 Q2	$111K	Buy	+1,013	New	+$106K	0.01%	299

Other funds holding DGX

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Washington Trust's DGX Position: Q3 2026 in Review

Washington Trust opened a new position in Quest Diagnostics (DGX) in Q3 2026: 960 shares worth $224K. The stake represents 0.01% of the portfolio and ranks #274 among its holdings. This is a return to the name: Washington Trust previously reported a position in DGX as recently as Q4 2025.

Washington Trust first reported a position in DGX in Q2 2018 and has held it in 25 quarters since. The position peaked at $311K in Q3 2025. 978 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

Washington Trust held 960 shares of Quest Diagnostics worth $224K as of Q3 2026.
Quest Diagnostics was a new Washington Trust position in Q3 2026.
Quest Diagnostics made up 0.01% of Washington Trust's portfolio in Q3 2026, its #274 holding.
Washington Trust first reported a position in Quest Diagnostics in Q2 2018 and has held it in 25 quarters since.
Washington Trust's Quest Diagnostics position peaked at $311K in Q3 2025.
978 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Washington Trust's 13F filing for Q3 2026, filed 22 Oct 2026.